Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Gilead

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Nov 19, 2020 10:52am

88 Views

Post# 31930469

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Gilead

I trust management is always trying to push the share price up. But they don't totally control the process of setting the stock's price. Broad-based insider buying is something that is helpful and this has happened before at least one previous stock offering that I recall. I am not sure I would call this latest bit of insider buying broad based as the two new directors were pretty much required to buy some shares.

I am not even sure TH is looking to raise cash, I am just speculating about it. Qwerty worries about insufficient data and I worry about phantom dilutive financings that are harmful to legacy shareholders. We all have our idiosyncriacies!